Your session is about to expire
← Back to Search
Sacubitril-Valsartan for Prediabetes
Study Summary
This trial is testing whether two drugs, valsartan and sacubitril, can improve blood sugar and insulin secretion better than valsartan alone in African Americans with impaired glucose tolerance.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your blood potassium level is higher than 5.0 milliequivalent/L.My kidney function is below normal levels.I have had heart problems or surgery in the last 6 months.You have a specific level of high blood sugar after drinking a sugary drink.I have had, or plan to have, weight loss surgery.I have been diagnosed with Type 2 Diabetes.I am African American, aged 18-65, with a history or risk factors for diabetes.I have lost more than 5% of my weight in the last 6 months.I am not on antipsychotic medication and do not have a severe psychiatric disorder.Your blood pressure is lower than 100 over 60.I am taking medication for heart or blood pressure issues.I have high blood pressure or I am on medication for it.I am currently taking steroids.I am taking oral medication for diabetes.
- Group 1: Valsartan
- Group 2: Sacubitril/Valsartan
- Group 3: Placebo
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please elaborate on other research conducted regarding Sacubitril-Valsartan Tab 97-103 MG?
"At present, there are 37 active clinical trials investigating the potential of Sacubitril-Valsartan Tab 97-103 MG with 8 in Phase 3. Montreal, Quebec is home to a majority of these studies but they can also be found at numerous other medical centres across North America (826 sites)."
Has the Federal Drug Administration given sanction to Sacubitril-Valsartan Tab 97-103 MG?
"The safety of Sacubitril-Valsartan Tab 97-103 MG is rated at a 3 due to the completion of Phase 4 trials and its official approval."
What medical conditions is Sacubitril-Valsartan Tab 97-103 MG most commonly employed to address?
"Sacubitril-Valsartan Tab 97-103 MG is regularly prescribed for the treatment of left ventricular dysfunction. Beyond this, it can be useful in addressing essential hypertension that hasn't responded to monotherapy and preventing cardiovascular incident."
What is the maximum capacity of participants for this clinical investigation?
"Affirmative. According to the info on clinicaltrials.gov, this medical trial is currently open for recruitment and was initially posted on February 25th 2020. It's looking to enroll 90 patients from a single site with its last update occurring in July 2021."
Who is eligible to take part in this research project?
"To qualify for this experiment, potential participants must display signs of impaired glucose tolerance and be between 18-65 years old. Presently, the study is aiming to recruit around 90 individuals."
Is this research endeavor welcoming individuals over the age of 35?
"This clinical research is open to participants aged between 18 and 65. Separately, there are 216 trials available for minors and 853 studies suitable for patients above the age of majority."
Is it still possible to enrol in this medical experiment?
"Affirmative. According to the data on clinicaltrials.gov, this experiment is currently seeking participants; it was first announced on February 25th 2020 and last revised in July 21st 2022. The research requires 90 people across a single medical institution."
Share this study with friends
Copy Link
Messenger